1,721,084 research outputs found
Commentary: second ipsilateral metachronous lung cancer: what to do?
No full textThe article by Hattori and colleagues1 deals with an interesting and still not sufficiently explored issue in thoracic
surgery: the role of repeated anatomic resection for radical
treatment of second metachronous ipsilateral non–small
cell lung cancer (NSCLC
Thoracic surgery for malignancy and emergency irrespective of COVID-19
Full text linkuntil March 24, 2020, a COVID-19 test by nasopharyngeal swab was offered to the patients presenting with
symptoms of COVID-19. However, from April 2, 2020, we
changed that policy, offering 2 COVID-19 tests by nasopharyngeal swab to everyone undergoing thoracic surgery
for malignancies before admission to our general university
hospital, even if asymptomatic
Stenting treatment is a minimally traumatic and effective alternative to surgical repair for iatrogenic tracheobronchial lesion
Full text linkIatrogenic tracheobronchial injuries are rare but lifethreatening events, most frequently due to complication
of endotracheal intubation or percutaneous tracheostomy.
Their incidence is low (0.005–0.2% after double lumen
or emergency single lumen intubation and up to 0.7%
after percutaneous tracheostomy), but related mortality
can be high and has been generally reported between
11% and 42% (1-5). Surgical repair has been considered
the treatment of choice for a long time. More recently,
along with the progressive evolution of interventional
bronchoscopy, minimally invasive endoscopic treatment has
gained diffusion as an effective alternative
Bronchovascular reconstruction in the era of mini-invasiveness
Full text linkbronchovascular reconstruction in the era of mininvasivenes
Pushing the limits in order to avoid pneumonectomy
Full text linkWe have read with great interest the letter from Dr. Perentes and colleagues (1) with his comments about our recent paper (2). Dr. Perentes agrees with our results affirming that for the treatment of centrally located lung cancer sleeve lobectomy should be preferred over pneumonectomy even after induction treatment. Our paper included patients undergoing Y sleeve lobectomy after neoadjuvant chemotherapy. Other experiences on sleeve lobectomy after induction treatment, reporting good results have been published (3-5). In their letter, the authors suggest that video-assisted thoracoscopic surgery (VATS) approach should be considered a viable option also when complex reconstructive operation like lower sleeve lobectomy are to be performed. This is an interesting point of view and published experiences on Y-sleeve lobectomy performed by VATS has been reported (4). We all have seen case videos and pictures of VATS sleeve; often we have not seen any picture or data on long-term results. Important technical issues that pertain difficult bronchial reconstructions can be addressed by a careful technique. In this setting, open surgery allows a more precise placement of the stiches in order to correct even large discrepancy of size between the bronchial stamps, to preserve the segmental bronchi division and to avoid the torsion of the bronchial axis. These are crucial technicalities when performing in particular lower sleeve lobectomy. Novel techniques have been proposed, in particular, for reconstruction of the pulmonary artery (in our opinion, tangential pulmonary artery repair should not be considered a real vascular reconstruction) (4,6). Therefore, pulmonary artery reconstruction (end-to end, patch or conduit) is not an issue anymore. The alternative among bronchial and/or vascular reconstruction, pneumonectomy, or irresectability is always an issue. If it has been demonstrated that easy and straightforward reconstructions can be made by VATS or robotic-assisted thoracoscopic surgery (RATS), this certainly does not apply to the majority of circumstances. Our paper maybe is not the first example of a contribution towards pushing the limits of what surgeon can achieve with sleeve lobectomy as Dr. Perentes and colleagues wrote; but our and other experiences suggest that every technical limit, when oncologically feasible, should be exceed in order to avoid pneumonectomy
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Erratum: Solitary Fibrous Tumor of the Pleura: Surgical Treatment and Recurrence (Thoracic and Cardiovascular Surgeon DOI: 10.1055/s-0043-1777260)
No full textIt has been brought to the publisher’s attention that the surname of the author “Antonio D’Andrilli” was appearing incorrect in the Journal of The Thoracic and Cardiovascular Surgeon, (DOI: 10.1055/s-0043-1777260). The surname has been corrected in the article
The advantage of sleeve lobectomy over pneumonectomy
Full text linkAnswer to Dr. Ludwig about lower sleeve lobectomy, the so-called “Y” sleeve
- …
